Skip to main content


3 Hot Reads From TheStreet's Top Premium Columnists

Jim Cramer and our other experts discuss the FAANG stocks, a market bottom, and potential biotech targets.

We Got Too Negative: Cramer's 'Mad Money' Recap

Jim Cramer says we're seeing powerful reminders that there's a better time to sell than in the teeth of a decline. Investors must use discipline to their advantage.

Markets Keep Eye on China Presidential Speech; Biotechs Bounce -- ICYMI

Here's what you need to know for Monday, April 9.

Dow Rises Sharply on Softer U.S. Approach in China Trade War; Tech Soars

Stocks rise Monday following tweets from Donald Trump that appeared to indicate the U.S. was softening its approach in its trade battle with China.

Video: Jim Cramer Reacts to Novartis' Acquisition of AveXis

Novartis agreed to acquire AveXis for $8.7 billion on Monday. TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer reacts.

Breaking News

Elon Musk Says Only Two Things Could Make Him Leave Tesla

Tesla CEO Musk discusses succession plans and Twitter with shareholders.

Caesars Inches Closer to Huge Las Vegas Strip Move

The company has made clear what it plans on the Las Vegas Strip, but it has a fast-approaching deadline.

Elon Musk Has Bad News About Tesla's Cybertruck

Long-delayed futuristic looking electric vehicle will be in production by the middle of 2023